Hydromorphone Extended-Release Tablets and Novoeight recombinant
Determining the interaction of Hydromorphone Extended-Release Tablets and Novoeight recombinant and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: hydromorphone
Brand name: Dilaudid, Exalgo, Hydrostat IR, Dilaudid-HP
Synonyms: Hydromorphone, HYDROmorphone
Generic Name: antihemophilic factor
Brand name: Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Hemofil-M, Koate-DVI, Monoclate-P, Jivi, Obizur
Synonyms: Novoeight (recombinant)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Hydromorphone Extended-Release Tablets-Novolin 70/30
- Hydromorphone Extended-Release Tablets-Novolin 70/30 (Insulin NPH and Insulin Regular (InnoLets, Pens, and PenFills))
- Hydromorphone Extended-Release Tablets-Novolin 70/30 (Insulin NPH and Insulin Regular (Vials))
- Hydromorphone Extended-Release Tablets-Novolin N
- Hydromorphone Extended-Release Tablets-Novolin N (Insulin NPH (InnoLets, Pens, and PenFill Cartridges))
- Hydromorphone Extended-Release Tablets-Novolin N (Insulin NPH (Vials))
- Novoeight recombinant-Hydromorphone Hydrochloride
- Novoeight recombinant-Hydromorphone injection
- Novoeight recombinant-Hydromorphone Liquid
- Novoeight recombinant-Hydromorphone rectal
- Novoeight recombinant-Hydromorphone Suppository
- Novoeight recombinant-Hydromorphone Tablets